Author:
Lengfelder E.,Seifarth W.,Hehlmann R.,Löffler H.,Fonatsch Ch.,Ludwig W. D.,Staib P.,Reichert A.,Wörmann B.,Hiddemann W.,Sauerland M. C.,Heinecke A.,Büchner Th.
Publisher
Springer Berlin Heidelberg
Reference13 articles.
1. Meng-er H,Yu-chen Y, Shu-rong C, Jin-ren C, JiaXiang L, Lin Z, Long-jun G, Zhen-yi W (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72: 567–572
2. Fenaux P, Castaigne S, Dombret H, Archimbaud E, Duarte M, Morel P, Lamy T, Tilly H, Guerci A, Maloisel F, Bordessoule D, Sadoun A, Tiberghien P, Fegueux N, Daniel MT, Chomienne C, Degos L (1992) All-trans retinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases. Blood 80: 2176–2181
3. Fenaux P, Le Deley MC, Castaigne S,Achimbaud E, Chomienne C, Link H, Guerci A, Duarte M, Daniel MT, Bowen D, Huebner G, Bauters F, Fe-gueux N, Fey M, Sanz M, Löwenberg B, Maloisel F, Auzanneau G, Sadoun A, Gardin C, Bastion Y, Ganser A, Jacky E, Dombret H, Chastang C, Degos L, and the European APL 91 Group (1993) Effect of all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized study. Blood 82: 3241–3249
4. Warrell RP Jr, Maslak P, Eardley A, Heller G, Miller WH, Frankel SR (1994) Treatment of acute promyelocytic leukemia with all-trans retinoic acid: An update of the New York experience. Leukemia 8: 020–933
5. Kanamaru A, Takemoto Y, Tanimoto M, Mura-kami H, Asou N, Kobayashi T, Kiriyama K, Oh-moto E, Sakamaki H, Tsubaki K, Hiraoka A, Yamada O, Oh H, Saito K, Matsuda S, Minato K, Ueda T, Ohno R, and the Japan Adult Leukemia Study Group (1995). All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Blood 85: 1202–1206